Yukishima T, Ebina K, Etani Y, Noguchi T, et al. Impact of switching from bisphosphonates to denosumab, teriparatide, or romosozumab in patients with postmenopausal osteoporosis: a case-control study. Osteoporos Int 2025 Jan 16. doi: 10.1007/s00198-025-07386.
PMID: 39821342